INTRODUCTION: This study aims to evaluate outcomes of bare-metal stents (BMS) versus drug-eluting stents (DES) in @entity1 who undergo stenting for transplant @entity2791 . MATERIALS AND METHODS: We retrospectively reviewed records of renal transplantation @entity1 who underwent transplant renal arterial stenting from September 2009 to September 2013. All stents greater than 5 mm were excluded to allow for equivalent comparison between the DES and BMS groups. Statistical comparisons were performed using a two-tailed Fischer exact test, and analysis of continuous variables was analyzed using a one-way analysis of variance. RESULTS: The final study population included a total of 18 @entity1 who received either BMS or DES (11 and 7 @entity1 , respectively) for transplant @entity2791 . The most common indications for stenting were increasing @entity1011 level and abnormal Doppler velocities. There were more re-interventions with BMS (n  = 4/11) than DES (n  = 0/7), but the trend was not statistically significant (P  = .12). Three @entity1 who received BMS had a clinically significant decrease in blood pressure versus 4 in the DES group (P  = .33). Six @entity1 who received BMS had a clinically significant decrease in @entity1011 level versus 3 in the DES group (P  = 1.0). CONCLUSION: There is an absolute but not statistically significant difference in the incidence of @entity256 requiring repeat intervention between the BMS and DES groups. No difference was detected in clinical success as measured by decreases in blood pressure or @entity1011 . Future larger studies are needed to corroborate these findings.

Renal Transplant XXXX Treated With Bare-Metal Versus Drug-Eluting Stents: Comparison of Treatment Outcomes.

@entity1 :: ('9606', 'Species') :: ['patients'] @entity2791 :: ('MESH:D012078', 'Disease') :: ['renal arterial stenosis'] @entity256 :: ('MESH:D023903', 'Disease') :: ['restenosis'] @entity1011 :: ('MESH:D003404', 'Chemical') :: ['creatinine']
@entity2791 :: (MESH:D012078,Disease) :: ['Arterial Stenosis']
